Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
10 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
UCB Belgium from Anderlecht, company number BE0402040254, closed financial year 2025 with a result of € 3,130 after tax. Compared with financial year 2024, the result moved from € 79,955 to € 3,130. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 20, 2026.
€ 4.1 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3,130
▼ 96% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.6 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,100
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 10 days on average.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 6,916 | € 135 | - | - | |
| Profit after taxes | € 80,270,883 | € 2,193,208 | € 79,955 | € 3,130 | ▼ 96% |
| Equity | € 111,759,423 | € 3,969,681 | € 4,049,636 | € 4,052,766 | |
| Total debts | € 55,466,319 | € 4,993,283 | € 7,840 | € 2,100 | ▼ 73% |
| Retained profit | € 4,259,423 | € 1,469,681 | € 1,549,636 | € 1,552,766 | |
| Dividend | € 55,462,400 | € 4,982,950 | € 0 | € 0 | |
| Balance sheet total | € 167,225,742 | € 8,962,964 | € 4,057,476 | € 4,054,866 | |
| Employees (FTE) | 0.1 | - | - | - |
Key figures of UCB Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to UCB Belgium?
What happened at UCB Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Raf REMIJSEN stepped down as director. NBB
- Caroline VANCOILLIE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 3,130 (▼ 96% vs 2024). Source: NBB ↗
- Xavier HORMAECHEA stepped down as director. NBB
- Raf REMIJSEN became a director. NBB
- Caroline VANCOILLIE became a director. NBB
- Xavier HORMAECHEA became a director. NBB
- New establishment in Anderlecht. KBO
In short
From € 80.3 million profit in 2022 to € 3,130 profit in 2025.
Paid € 215,806 in corporate taxes since 2022.
Best year ever: 2022, with € 80.3 million profit.
Paid out € 60.4 million in dividends to the owners in total.
Management
The shares are held by UCB PHARMA SA (100%). It owns 100% of UCB FIPAR SA itself.
Directors
According to the 2025 annual accounts
Caroline VANCOILLIE
Director
since 2024 · until 2030
Raf REMIJSEN
Director
since 2025 · until 2031
Xavier HORMAECHEA
Managing director
since 2023 · until 2026
Shareholders
100%
Participations
100%
Establishments
Establishment units
Physical locations of this company
Researchdreef 60
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
All companies at this address →U C B
UCB PHARMA same network
€ 4.6 billion revenue · 2025
UCB Fipar same network
Fondation Emmanuel Janssen
UCB BIOPHARMA
€ 3.6 billion revenue · 2025
+5 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0402.040.254
- VAT number
- BE 0402.040.254
- Registered office
- Researchdreef 60, 1070 Anderlecht
- Names & denominations
- UCB Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 July 1919
- Peppol
- Active · Active since 12 Dec 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Overige ondersteunende activiteiten in verband met financiële diensten, neg, exclusief verzekeringen en pensioenfondsen